Pfizer leans toward spinoff
Pfizer Inc. is leaning toward a spinoff of its animal health business, viewing a sale as less compelling because of a potentially heavy tax bill and antitrust scrutiny, people familiar with the matter said.
Pfizer said it has hired advisers to review options for its Capsugel business, according to a Wall Street Journal report, which could include a possible sale of the unit.